• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

This Week in the C-Suite


It has been a week like no other.

C-Suite offices were empty or minimally occupied-social distance ghost towns replaced by home offices, conference calls, and instant messaging.

WFH, the new norm of abnormal times. With important exceptions-exception like brave healthcare workers, many in dire need of personal protective equipment.

For many, social distancing was not walk in the park-although walks in the park are allowed.

Some parts of the healthcare sector ran as fast they could. Like telehealth, which had a date with history that it’s hoping will turn into a permanent relationship. Government health officials at all levels. Labs testing for SARS-CoV-2. Doctors and nurses in hotspots like California,  New York, and Washington state.

Time warped.

“Last week was a year ago, right?” half-joked Michael Barnett, an assistant professor at the Harvard T.H. Chan School of Public Health, when we interviewed him for a story about telehealth.

And time didn’t matter.

“The clock is meaningless now,” said Cynthia Hundorfean, president and CEO of Allegheny Health Network in western Pennsylvania, and a member of our editorial advisory board.

Congress, the White House, governors, mayors, insurers, hospitals, drugmakers-they did act. The right way? Weeks late and millions of test kits too short? That’s worthy of a long, separate discussion.

But amid the general anxiety about COVID-19 and the specter of a severe economic downturn are the palliatives of many crises: admiration for dedicated people, gratitude for the acts and offers of help, and a rare sense of unity.  e of unity of who throw themselves into the dealing with the work that people and unity.

After Congress passed the Families First Coronavirus Response Act, which, among other things increased the federal share of Medicaid funding, Margaret Murray, CEO of the Association for Community Affiliated Plans, applauded the alacrity and leadership.

“If this crisis holds a silver lining,” Murray, who is a member of our editorial advisory board, “it’s that it demonstrates that Congress can pull together and provide Americans with needed relief to get through these unprecedented circumstances.”

Here’s to silver linings, staying safe, and cradling hope that next week in the C-suite will improve on this one.

Related Videos
Video 2 - "Addressing Coexisting Conditions: Keys to Comprehensive Diabetes Care"
Video 1 - "The Influence of Social Determinants of Health on Diabetes Care and Outcomes"
Gabriela Hobbs, MD, and Timothy Mok, PharmD, BCPS, BCOP
Video 4 - "Enhancing Patient Understanding and Treatment Adherence"
Video 2 - "Overview of Treatments for Atopic Dermatitis"
Video 3 - "In-Office Procedures, Over-the-Counter Options, Treatment Delays, and Costs"
Video 6 - "Safety Analysis and Interpreting Results from MAJIC-PV"
Video 5 - "Key Findings from MAJIC-PV"
Related Content
© 2024 MJH Life Sciences

All rights reserved.